[
  {
    "ts": null,
    "headline": "Is ResMed Fairly Priced After Recent Patent Dispute Settlement in 2025?",
    "summary": "If you have been eyeing ResMed stock and wondering what your next move should be, you are not alone. Over the last year, shares have climbed an impressive 14.1%, with gains of 32.0% over three years and nearly 57% in the past five. Of course, in the short term, it has not all been smooth sailing. This past week saw a modest dip of 2.4%, and the stock has moved up just 0.7% over the last month. Overall, the broader trend suggests that investors continue to see promise, likely fueled by...",
    "url": "https://finnhub.io/api/news?id=71c32cf3ad79e5bfab9112d6f1c7a64bc42a46a378027f3d89d13bf64823c888",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760278078,
      "headline": "Is ResMed Fairly Priced After Recent Patent Dispute Settlement in 2025?",
      "id": 137063846,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "If you have been eyeing ResMed stock and wondering what your next move should be, you are not alone. Over the last year, shares have climbed an impressive 14.1%, with gains of 32.0% over three years and nearly 57% in the past five. Of course, in the short term, it has not all been smooth sailing. This past week saw a modest dip of 2.4%, and the stock has moved up just 0.7% over the last month. Overall, the broader trend suggests that investors continue to see promise, likely fueled by...",
      "url": "https://finnhub.io/api/news?id=71c32cf3ad79e5bfab9112d6f1c7a64bc42a46a378027f3d89d13bf64823c888"
    }
  }
]